|
⚲
|
| Keyboard |
| Venrock Management VII LLC | |
|---|---|
| Firm | VR Management LLC |
| Address | 3340 Hillview Avenue Palo Alto, CA 94304 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| VR Management LLC | |||||
| Venrock Associates VII LP | 021-222342 | Director | 415.6 M of 415.6 M |
1,581.4 M | |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Cyteir Therapeutics Inc CYT
Common Stock
|
2021-06-22 | Conversion | 3,259,025 | ||
|
Cyteir Therapeutics Inc CYT
Series B Convertible Preferred Stock · derivative
|
2021-06-22 | Conversion | 10,000,000 | ||
|
Cyteir Therapeutics Inc CYT
Series C Convertible Preferred Stock · derivative
|
2021-06-22 | Conversion | 1,109,368 | ||
|
Shockwave Medical Inc SWAV
Common Stock
|
2019-03-11 | Conversion | 1,016,492 | ||
|
Shockwave Medical Inc SWAV
Series B Convertible Preferred Stock · derivative
|
2019-03-11 | Conversion | 1,105,529 | ||
|
Shockwave Medical Inc SWAV
Common Stock
|
2019-03-11 | Conversion | 1,105,529 | ||
|
Shockwave Medical Inc SWAV
Series C Convertible Preferred Stock · derivative
|
2019-03-11 | Conversion | 1,016,492 |